While L1CAM protein expression has been connected to serous and clear cell histology as well as abnormal p53 status (subsequently correlating with worse outcome), there is also evidence suggesting a p53-independent L1CAM in endometrial carcinoma molecular subtypes [35,41,42,43]. The gene discussed is TP53; the disease is endometrial carcinoma.